NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
July 10, 2025 16:30 ET Â | Source: NKGen Biotech, Inc. SANTA ANA,…
IEP – ‘The Great Fragmentation’ Driving Conflict: World Peace Plummets
LONDON, June 18, 2025 /PRNewswire/ -- The 2025 Global Peace Index (GPI),…
